title: [Effects of synthetic salmon calcitonin and alendronate on bone quality in ovariectomized rats].
abstract: BACKGROUND
  The aim of this study was to assess the effect of calcitonin (CCT) and alendronate (ALN) on bone quality through histomorphometric, histological, densitometric and crystallographic evaluations in an experimental model of osteoporosis obtained in ovariectomized rats.
  
  
  METHODS
  The animals were randomly assigned to the treatment with CCT (2 IU/kg/day, N-12) or with ALN (6 micrograms/kg/day, N-12) given subcutaneously, starting three months after ovariectomy: treatment lasted 60 days. Six rats untreated after ovariectomy and other 6 non ovariectomized (intact) were taken as controls. At the end of treatment the animals were sacrificed and femurs explanted for laboratory examinations. Results were evaluated by an ANOVA followed by the Tukey's test when appropriate.
  
  
  RESULTS
  The histomorphometric analysis showed a significant increase of the trabecular bone volume and of the cortical bone thickness either with CCT and ALN in comparison with the ovariectomized untreated controls. Optic and electronic microscopy examinations suggest a higher bone remodeling after ALN than after CCT, but accompanied by areas of imperfect mineralization, and more irregular osteon and collagen fibres disposition. The densitometry carried out at the femoral head and diaphysis showed a similar bone mass increase following either CCT and ALN, but significantly higher in comparison to the untreated controls. At the diaphysis level ALN was superior in increasing the bone mass also when compared to the intact rats. The mineralogic exams showed that CCT acted on the re-elaboration of the mineral phase approaching the molar ratio Ca/PO4 to the physiological values typical of senescence, and crystallography revealed that the formation of hydroxyapatite crystals follows a physiological mineral redeposition: those phenomena were not observed for ALN.
  
  
  CONCLUSIONS
  In conclusion both CCT and ALN could reduce the bone loss due to osteoporosis, by increasing the bone mass and thickness. Nevertheless the submicroscopic and chemical bone structure are less similar to the physiologic ones after treatment with ALN.
authors.affiliation: Servizio di Chirurgia Sperimentale, Istituto Ortopedico Rizzoli, Bologna.
authors.forename: R
authors.initials: R
authors.lastname: Giardino
authors.forename: M
authors.initials: M
authors.lastname: Fini
authors.forename: N
authors.initials: N
authors.lastname: Nicoli Aldini
authors.forename: S
authors.initials: S
authors.lastname: Gnudi
authors.forename: G
authors.initials: G
authors.lastname: Biagini
authors.forename: M G
authors.initials: MG
authors.lastname: Gandolfi
authors.forename: R
authors.initials: R
authors.lastname: Mongiorgi
mesh_terms: D019386:Alendronate / Q000494:pharmacology* / Q000627:therapeutic use; D000704:Analysis of Variance; D000818:Animals; D015519:Bone Density; D001842:Bone and Bones / Q000033:anatomy & histology / Q000187:drug effects*; D002116:Calcitonin / Q000494:pharmacology* / Q000627:therapeutic use; D003461:Crystallography; D005260:Female; D008954:Models, Biological; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy*; D010052:Ovariectomy; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: C028815:salmon calcitonin; D002116:Calcitonin; D019386:Alendronate
vernacular_title: Effetti di calcitonina sintetica di salmone ed alendronato sulla qualità dell'osso in ratte ovariectomizzate.